, Tracking Stock Market Picks
Enter Symbol:
Gentium Spa (GENTY) [hlAlert]

up 186.80 %

Gentium Spa (GENT) rated Buy

Posted on: Tuesday,  Aug 21, 2007  9:25 AM ET by Oppenheimer

Oppenheimer rated Buy Gentium Spa (OTCBB: GENTY) on 08/21/2007, when the stock price was $19.56. Since
then, Gentium Spa has gained 186.81% as of 04/11/2014's recent price of $56.10.
If you would have followed this Oppenheimer's recommendation on GENTY, you would have gained 186.8% of your investment in 2425 days.

Gentium S.p.A. is a biopharmaceutical company focused on the development and manufacture of defibrotide, a deoxyribonucleic acid (DNA) based drug derived from pig intestines, to treat and prevent a disease called hepatic veno-occlusive disease (VOD), a condition in which some of the veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation treatments that are given prior to stem cell transplantation. The Company is concluding a Phase III clinical trial of defibrotide to treat severe VOD in the United States, Canada and Israel. The Company is also conducting a Phase II/III clinical trial of defibrotide in Europe to prevent VOD in children. In addition to defibrotide, the Company sells urokinase, calcium heparin, sodium heparin and sulglicotide, which are active pharmaceutical ingredients used to make other drugs.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/21/2007 9:25 AM Buy
19.56 30.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy